skip to Main Content
Dr. Tanios Bekaii-Saab

Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor

That’s the question researchers hoped to answer in a phase II double-blind trial comparing mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients. Results of the trial were presented at the 2021 ASCO GI Cancer Symposium. Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2, a vascular…

Pancreatic cancer patient Eric Lasner racing in a green and blue car

My Most Challenging Race

Eric Lasner faced Whipple surgery, chemotherapy with FOLFIRINOX, and radiation, in order to get back to closed circuit road racing.

pancreatic cancer patient Michael Florio and his family

The Importance of Family and Friends

Michael Florio has been able to count on his family and friends to get him to pancreatic cancer treatment and support him through a Whipple procedure.

Back To Top